@FiercePharma: Sanofi cuts 1,700 U.S. jobs. Article | Follow @FiercePharma
Special Report: FDA's Top 10 Blockbuster Decisions. Report
> French pharmaceutical company Ipsen said it was ditching CEO Jean-Luc Bélingard, citing "strategic differences" over the group's development; he'll be replaced by Marc de Garidel, 52, formerly an Amgen vice president. Ipsen release | Report
> H. Lundbeck, the Danish drugmaker looking for replacements for its blockbuster antidepressant Lexapro, agreed to buy the rights to sell Merck's bipolar disorder treatment Sycrest. Lundbeck release | Report
> An arm of Citigroup and two other investors are mulling a sale of copycat drugmaker Biofarma, people familiar with the matter said, in what could be Turkey's biggest healthcare deal. Item
> Eli Lilly has sued Dr Reddy's Laboratories for infringing the patent on its cancer drug Gemzar. Report
> Despite its recent withdrawal from the market, the weight-loss drug Meridia (sibutramine) is likely to remain available through weight-loss nutritional supplements containing undeclared prescription-strength ingredients and other contaminants. News
> GlaxoSmithKline is to put British university students to work to discover the drugs of the future in a training program that will tap into the skills of the next generation of chemists at minimal cost. Report
> Taking folic acid supplements for five years seems to have no significant benefit for the prevention of cardiovascular disease or cancer, according to a meta-analysis. Article
Biotech News
@FierceBiotech: Jazz shares hit sour note as FDA rejects fibromyalgia drug. Article | Follow @FierceBiotech
@JohnCFierce: Once heard Peter Drucker talk about U.S. tech revolutions. 1st years: Disaster, as everyone piles into the hype. 2nd 10 years: Revolution.| Follow @JohnCFierce
> History or hype? World's first ESC trial gets under way. News
> Halozyme chops preclinical ops in restructuring. Story
> Pfizer embraces pain pipeline in $3.6B King buyout. Article
> Euro-US hybrid Synosia lands $745M Parkinson's pact with UCB. Story
> Pfizer lung cancer drug looks promising in mid-stage study. Article
Biotech Research News
> Gelesis makes anti-obesity progress. Story
> Should human genes be patented? Item
> Scientists, lawyer 'unzip' their DNA for the world. News
> U.K. company develops weapon against hospital 'superbug'. Article
> Stem cell research in the embryonic stage. Report
> So you want to lead an innovative company? Respect the innovators. Story
Manufacturing News
> Hijacking, break-in mark recent cargo heists. Story
> FDA offers formatted data on recalls. Report
> Caraco tallies timing of consent decree fixes. Item
> Lipitor recall shares pallets, Puerto Rico with Tylenol, Glumetza. Article
> HHS takes both sides of egg bet for vax-making. Report
> India foresees spread of generics seizures via ACTA. News
And Finally... Urinary tract infections, pneumonia and other common ailments caused by germs that carry a new gene with the power to destroy antibiotics are intensifying fears of a fresh generation of so-called superbugs. Report